Millennium Management’s Avidity Biosciences RNAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,157,270
| Closed | -$156M | – | 6285 |
|
|
2025
Q4 | $156M | Buy |
2,157,270
+2,127,647
| +7,182% | +$137M | 0.07% | 271 |
|
|
2025
Q3 | $1.29M | Sell |
29,623
-207,368
| -88% | -$8.38M | ﹤0.01% | 4415 |
|
|
2025
Q2 | $6.73M | Buy |
236,991
+219,943
| +1,290% | +$6.56M | ﹤0.01% | 2673 |
|
|
2025
Q1 | $503K | Sell |
17,048
-6,893
| -29% | -$215K | ﹤0.01% | 4805 |
|
|
2024
Q4 | $696K | Buy |
23,941
+5,405
| +29% | +$226K | ﹤0.01% | 4483 |
|
|
2024
Q3 | $851K | Sell |
18,536
-106,839
| -85% | -$4.64M | ﹤0.01% | 4400 |
|
|
2024
Q2 | $5.12M | Sell |
125,375
-43,216
| -26% | -$1.24M | ﹤0.01% | 2708 |
|
|
2024
Q1 | $4.3M | Sell |
168,591
-172,025
| -51% | -$2.7M | ﹤0.01% | 3011 |
|
|
2023
Q4 | $3.08M | Sell |
340,616
-399,880
| -54% | -$2.67M | ﹤0.01% | 3221 |
|
|
2023
Q3 | $4.72M | Buy |
740,496
+695,356
| +1,540% | +$5.99M | ﹤0.01% | 2740 |
|
|
2023
Q2 | $501K | Buy |
+45,140
| New | +$566K | ﹤0.01% | 4545 |
|
|
2023
Q1 | – | Sell |
-750,445
| Closed | -$16.7M | – | 6780 |
|
|
2022
Q4 | $16.7M | Buy |
750,445
+711,532
| +1,829% | +$10.6M | 0.01% | 1618 |
|
|
2022
Q3 | $635K | Buy |
+38,913
| New | +$744K | ﹤0.01% | 4743 |
|
|
2022
Q1 | – | Sell |
-19,053
| Closed | -$453K | – | 7394 |
|
|
2021
Q4 | $453K | Buy |
19,053
+3,693
| +24% | +$88.2K | ﹤0.01% | 5138 |
|
|
2021
Q3 | $378K | Buy |
15,360
+7,260
| +90% | +$158K | ﹤0.01% | 5618 |
|
|
2021
Q2 | $200K | Sell |
8,100
-84,996
| -91% | -$1.98M | ﹤0.01% | 6024 |
|
|
2021
Q1 | $2.03M | Sell |
93,096
-11,120
| -11% | -$272K | ﹤0.01% | 3519 |
|
|
2020
Q4 | $2.66M | Buy |
+104,216
| New | +$3.04M | ﹤0.01% | 3003 |
|
|
2020
Q3 | – | Sell |
-226,044
| Closed | -$6.39M | – | 4762 |
|
|
2020
Q2 | $6.39M | Buy |
+226,044
| New | +$6.52M | 0.01% | 1557 |
|
Other funds holding RNAM
Millennium Management's RNAM Position: Q1 2026 in Review
Millennium Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,157,270 shares — an estimated $156M sold.
Millennium Management first reported a position in RNAM in Q2 2020 and held it in 19 quarters. The position peaked at $156M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.
- Millennium Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
- Millennium Management sold 2,157,270 Avidity Biosciences shares in Q1 2026, an estimated $156M.
- Millennium Management first reported a position in Avidity Biosciences in Q2 2020 and held it in 19 quarters.
- Millennium Management's Avidity Biosciences position peaked at $156M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.